UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044710
Receipt number R000050908
Scientific Title Comparison of the usefulness of INVOS and ICG fluorescence method as a method for evaluating residual intestinal blood flow during gastrointestinal resection surgery
Date of disclosure of the study information 2021/06/30
Last modified on 2023/01/06 10:35:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of the usefulness of INVOS during intestinal resection surgery and blood flow evaluation by ICG fluorescence method.

Acronym

Comparison of blood flow evaluation by INVOS and ICG fluorescence method at the time of intestinal resection

Scientific Title

Comparison of the usefulness of INVOS and ICG fluorescence method as a method for evaluating residual intestinal blood flow during gastrointestinal resection surgery

Scientific Title:Acronym

Comparison of the usefulness of INVOS and ICG fluorescence method as a method for evaluating residual intestinal blood flow during gastrointestinal resection surgery

Region

Japan


Condition

Condition

esophageal and gastrointestinal and colorectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To measure oxygen saturation using INVOS in the intestine to be resected and in the remaining intestine in patients undergoing gastrointestinal resection and to evaluate whether it can be used as an indirect index of blood flow assessment, and to evaluate blood flow assessment at the same site using ICG fluorescence and to evaluate the correlation with blood flow assessment by INVOS.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

INVOS oxygen saturation of residual intestine

Key secondary outcomes

Evaluation of correlation between INVOS tissue saturation and ICG fluorescence method, ICG fluorescence intensity, oxygen saturation, oxygen partial pressure, blood oxygen content, oxygen supply, oxygen consumption, oxygen uptake rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

INVOS measurement, ICG fluorescence method measurement

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled for gastrointestinal resection at our hospital

Key exclusion criteria

Patients under 20 years old

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Egi

Organization

Ehime University

Division name

Gastrointestinal Surgery and Surgical oncology

Zip code

791-0295

Address

454 Shitsukawa, Toon City, Ehime

TEL

0899605975

Email

egi.hiroyuki.if@ehime-u.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Ogi

Organization

Ehime University

Division name

Gastrointestinal Surgery and Surgical oncology

Zip code

791-0295

Address

454 Shitsukawa, Toon City, Ehime

TEL

0899605975

Homepage URL


Email

ogi.yusuke.xx@ehime-u.ac.jp


Sponsor or person

Institute

Ehime University

Institute

Department

Personal name



Funding Source

Organization

Ehime University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board,Ehime University Hospital

Address

Shitsukawa, Toon City, Ehime

Tel

089-960-5172

Email

rinri@m.ehime-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 06 Month 01 Day

Date of IRB

2021 Year 06 Month 29 Day

Anticipated trial start date

2021 Year 06 Month 29 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 06 Month 30 Day

Last modified on

2023 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050908


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name